Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma

被引:0
|
作者
Raed M. Alnaji
William Du
Emmanuel Gabriel
Smit Singla
Kristopher Attwood
Hector Nava
Usha Malhotra
Steven N. Hochwald
Moshim Kukar
机构
[1] Roswell Park Cancer Institute,Department of Surgical Oncology
[2] New Center for Excellence,Department of Biostatistics
[3] Roswell Park Cancer Institute,Department of Medical Oncology
来源
关键词
Esophageal adenocarcinoma; Neoadjuvant therapy; Pathologic complete response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1541 / 1546
页数:5
相关论文
共 50 条
  • [41] Prediction of pathologic complete response to neoadjuvant therapy for esophageal adenocarcinoma using copy number alterations
    Qian, David C.
    Lefferts, Joel A.
    Zaki, Bassem I.
    Mishyn, Pavlo
    Brickley, Elizabeth B.
    Xue, Yue
    Lisovsky, Mikhail
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [42] Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma
    McLaren, Patrick J.
    Barnes, Anthony P.
    Terrell, Willy Z.
    Vaccaro, Gina M.
    Wiedrick, Jack
    Hunter, John G.
    Dolan, James P.
    [J]. AMERICAN JOURNAL OF SURGERY, 2017, 213 (05): : 915 - 920
  • [43] Pathologic Response to Neoadjuvant Chemotherapy and Chemoradiation in Borderline Resectable Adenocarcinoma of the Pancreas
    Lee, Joon K.
    Ghanem, Ahmed I.
    Burmeister, Charlotte
    Jaratli, Hayan
    Raoufi, Mohammad
    Khan, Gazala
    Dobrosotskaya, Irina
    Kwon, David
    Siddiqui, Farzan
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E4 - E4
  • [44] Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?
    Susanna W. L. de Geus
    Sameer Hirji
    Krista J. Hachey
    Teviah E. Sachs
    Kei Suzuki
    Sing Chau Ng
    Scott Swanson
    Virginia R. Litle
    Thomas D’Amico
    Jennifer F. Tseng
    [J]. Journal of Gastrointestinal Surgery, 2020, 24 : 2447 - 2455
  • [45] Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?
    de Geus, Susanna W. L.
    Hirji, Sameer
    Hachey, Krista J.
    Sachs, Teviah E.
    Suzuki, Kei
    Ng, Sing Chau
    Swanson, Scott
    Litle, Virginia R.
    D'Amico, Thomas
    Tseng, Jennifer F.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (11) : 2447 - 2455
  • [46] CEA as a Predictor of Pathologic Tumor Response Following Long Course Neoadjuvant Chemoradiation Therapy for Rectal Cancer
    Shaffer, J.
    Koong, A. C.
    Chang, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E167 - E167
  • [47] Rapidly Extensive Recurrence of Esophageal Neuroendocrine Carcinoma Following Complete Pathologic Response to Definitive Chemoradiation
    Wang, Maxwell M.
    Singh, Simi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S998 - S999
  • [48] Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
    Villano, Anthony M.
    O'Halloran, Eileen
    Goel, Neha
    Ruth, Karen
    Barrak, Dany
    Lefton, Max
    Reddy, Sanjay S.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 502 - 512
  • [49] Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
    Berger, AC
    Farma, J
    Scott, WJ
    Freedman, G
    Weiner, L
    Cheng, JD
    Wang, H
    Goldberg, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4330 - 4337
  • [50] Patterns of recurrence after complete pathologic response to neoadjuvant chemoradiation in esophageal carcinoma: Report from northeast of Iran
    Ali, Taghizadeh
    Mona, Joudi
    Alexander, Heriot
    Mohsen, Aliakbarian
    Ehsan, Soltani
    Reza, Bagheri
    Elahe, Aghel
    [J]. ANNALS OF ONCOLOGY, 2017, 28